AAAAAA

   
Results: 1-14 |
Results: 14
R-Ras regulation of integrin function
Authors: Hughes, PE Oertli, B Han, JW Ginsberg, MH
Citation: Pe. Hughes et al., R-Ras regulation of integrin function, METH ENZYM, 333, 2001, pp. 163-171
Integrin activation controls metastasis in human breast cancer
Authors: Felding-Habermann, B O'Toole, TE Smith, JW Fransvea, E Ruggeri, ZM Ginsberg, MH Hughes, PE Pampori, N Shattil, SJ Saven, A Mueller, BM
Citation: B. Felding-habermann et al., Integrin activation controls metastasis in human breast cancer, P NAS US, 98(4), 2001, pp. 1853-1858
Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism
Authors: Ramos, JW Hughes, PE Renshaw, MW Schwartz, MA Formstecher, E Chneiweiss, H Ginsberg, MH
Citation: Jw. Ramos et al., Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism, MOL BIOL CE, 11(9), 2000, pp. 2863-2872
The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function
Authors: Oertli, B Han, J Marte, BM Sethi, T Downward, J Ginsberg, M Hughes, PE
Citation: B. Oertli et al., The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function, ONCOGENE, 19(43), 2000, pp. 4961-4969
Neuroprotective strategies for basal ganglia degeneration: Parkinson's andHuntington's diseases
Authors: Alexi, T Borlongan, CV Faull, RLM Williams, CE Clark, RG Gluckman, PD Hughes, PE
Citation: T. Alexi et al., Neuroprotective strategies for basal ganglia degeneration: Parkinson's andHuntington's diseases, PROG NEUROB, 60(5), 2000, pp. 409-470
Variable susceptibility to neurotoxicity of systemic 5-nitropropionic acid
Authors: Alexi, T Faull, RLM Hughes, PE
Citation: T. Alexi et al., Variable susceptibility to neurotoxicity of systemic 5-nitropropionic acid, CONT NEUROS, 2000, pp. 129-140
The small GTP-binding protein R-Ras can influence integrin activation by antagonizing a Ras/Raf-initiated integrin suppression pathway
Authors: Sethi, T Ginsberg, MH Downward, J Hughes, PE
Citation: T. Sethi et al., The small GTP-binding protein R-Ras can influence integrin activation by antagonizing a Ras/Raf-initiated integrin suppression pathway, MOL BIOL CE, 10(6), 1999, pp. 1799-1809
A note on the effects of contact frequency and time of day of boar exposure on the efficacy of the boar effect
Authors: Hughes, PE Thorogood, KL
Citation: Pe. Hughes et Kl. Thorogood, A note on the effects of contact frequency and time of day of boar exposure on the efficacy of the boar effect, ANIM REPROD, 57(1-2), 1999, pp. 121-124
Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease
Authors: Hughes, PE Alexi, T Williams, CE Clark, RG Gluckman, PD
Citation: Pe. Hughes et al., Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease, NEUROSCIENC, 92(1), 1999, pp. 197-209
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system
Authors: Hughes, PE Alexi, T Walton, M Williams, CE Dragunow, M Clark, RG Gluckman, PD
Citation: Pe. Hughes et al., Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system, PROG NEUROB, 57(4), 1999, pp. 421-450
The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease
Authors: Alexi, T Hughes, PE van Roon-Mom, WMC Faull, RLM Williams, CE Clark, RG Gluckman, PD
Citation: T. Alexi et al., The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease, EXP NEUROL, 159(1), 1999, pp. 84-97
Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat
Authors: Wu, DD Lai, M Hughes, PE Sirimanne, E Gluckman, PD Williams, CE
Citation: Dd. Wu et al., Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat, BRAIN RES, 835(2), 1999, pp. 369-378
Genetic and pharmacological analyses of Syk function in alpha(IIb)beta(3) signaling in platelets
Authors: Law, DA Nannizzi-Alaimo, L Ministri, K Hughes, PE Forsyth, J Turner, M Shattil, SJ Ginsberg, MH Tybulewicz, VLJ Phillips, DR
Citation: Da. Law et al., Genetic and pharmacological analyses of Syk function in alpha(IIb)beta(3) signaling in platelets, BLOOD, 93(8), 1999, pp. 2645-2652
The death effector domain of PEA-15 is involved in its regulation of integrin activation
Authors: Ramos, JW Kojima, TK Hughes, PE Fenczik, CA Ginsberg, MH
Citation: Jw. Ramos et al., The death effector domain of PEA-15 is involved in its regulation of integrin activation, J BIOL CHEM, 273(51), 1998, pp. 33897-33900
Risultati: 1-14 |